Simultaneous determination of paroxetine and sertraline in human plasma by RP-HPLC

Journal of China Pharmaceutical University

Volumn 34, Issue 2, 2003, Pages 141-143

  Chen, Ying ^a   Xiao, Hong ^a   Wu, Ru Jin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Determination of content; Paroxetine; Plasma; RP HPLC; Sertraline

Indexed keywords

AMITRIPTYLINE; PAROXETINE; SERTRALINE;

ARTICLE; DRUG ANALYSIS; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG MONITORING; LIQUID PHASE MICROEXTRACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 29144464233     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Eap CB, Baumann P. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients[J]. Chromatogr B, 1996,686:51-63.
2. Lopez-Calull C, Dominguez N. Determination of paroxetine in plasma by high-performance liquid chromatography for bioequivalence studies [J]. Chromatogr B, 1999,724:393-398.
3. Foglia JP, Sorisio D, Kirshner M, et al. Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection[J]. Chromatogr B, 1997,693:147-151.
4. Rogowsky D, Marr M, Long G, et al. Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry[J]. Chromatogr B, 1994,655:138-141.